The mucosal immune system: features of inductive and effector sites to consider in mucosal immunization and vaccine development.
Kiyono
H
H
Department of Oral Biology, University of Alabama, Birmingham 35294.
Bienenstock
J
J
McGhee
J R
JR
Ernst
P B
PB
D000284:Administration, Oral; D000818:Animals; D001980:Bronchi / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D006801:Humans; D007114:Immunization / Q000379:methods*; D007070:Immunoglobulin A / Q000096:biosynthesis / Q000276:immunology; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis / Q000276:immunology; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007413:Intestinal Mucosa / Q000276:immunology; D016131:Lymphocyte Subsets / Q000276:immunology; D008221:Lymphoid Tissue / Q000276:immunology*; D051379:Mice; D008808:Mice, Inbred CBA / Q000276:immunology; D008817:Mice, Mutant Strains / Q000276:immunology; D009092:Mucous Membrane / Q000276:immunology*; D015213:Neuroimmunomodulation; D009490:Neurosecretory Systems / Q000502:physiology; D014612:Vaccines / Q000008:administration & dosage*
D016207:Cytokines; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D014612:Vaccines; C034639:polymeric IgA